Literature DB >> 3499500

Elastase-alpha 1-proteinase inhibitor: an early indicator of septicemia and bacterial meningitis in children.

C P Speer1, M Rethwilm, M Gahr.   

Abstract

In 26 infants and children with septicemia or bacterial meningitis, significantly elevated plasma levels of elastase-alpha 1-proteinase inhibitor (E-alpha 1-PI) were present at time of recognition of infection, even in those patients with neutropenia (range of reference values: 25 to 190 micrograms/L, n = 142; patients: 444 to 2049 micrograms/L, n = 26). After initiation of therapy, normalization of E-alpha 1-PI levels was observed in all patients who recovered from infection. In addition, 18 of 19 children with bacterial meningitis had increased cerebrospinal fluid concentrations of E-alpha 1-PI above the range of normal (range of reference values: 0 to 39 micrograms/L, n = 62; patients: 30 to 3490 micrograms/L, n = 19); concentrations of E-alpha 1-PI in bacterial meningitis were significantly increased when compared with those in aseptic meningitis (range 25 to 194 micrograms/L; n = 15). In 30 patients with local bacterial infections (pneumonia, urinary tract infections, etc.), E-alpha 1-PI was also elevated. These data suggest that E-alpha 1-PI is a sensitive indicator of systemic and local bacterial infection in childhood.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499500     DOI: 10.1016/s0022-3476(87)80240-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin.

Authors:  V Gross; J Schölmerich; H G Leser; R Salm; M Lausen; K Rückauer; U Schöffel; L Lay; A Heinisch; E H Farthmann
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

3.  Proteinase-antiproteinase imbalance in meningitis: determination of alpha 1 proteinase inhibitor (alpha 1PI), elastase-alpha 1PI complex, and elastase inhibition capacity in cerebrospinal fluid.

Authors:  J van Wees; F K Tegtmeyer; J Otte; W G Wood; J Braun
Journal:  Klin Wochenschr       Date:  1990-11-09

4.  Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.

Authors:  A N Neely; R G Miller; I A Holder
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  PMN-elastase in assessment of patients with inflammatory bowel disease.

Authors:  T Andus; V Gross; I Caesar; D Krumm; J Hosp; W Gerok; J Schölmerich
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

6.  Neutrophil function in children following allogeneic hematopoietic stem cell transplant.

Authors:  Michael W Kent; Marguerite R Kelher; Christopher C Silliman; Ralph Quinones
Journal:  Pediatr Transplant       Date:  2016-04-25

7.  Serum tumour necrosis factor in newborns at risk for infections.

Authors:  E P Girardin; M E Berner; G E Grau; S Suter; G Lacourt; L Paunier
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

8.  Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.

Authors:  C P Speer; O Gefeller; P Groneck; E Laufkötter; C Roll; L Hanssler; K Harms; E Herting; H Boenisch; J Windeler
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-01       Impact factor: 5.747

9.  Application of mass spectrometry to elucidate the pathophysiology of Encephalitozoon cuniculi infection in rabbits.

Authors:  Guillaume Desoubeaux; Maria Del Carmen Piqueras; Ana Pantin; Sanjoy K Bhattacharya; Roman Peschke; Anja Joachim; Carolyn Cray
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.